385 related articles for article (PubMed ID: 22549783)
1. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA
J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783
[TBL] [Abstract][Full Text] [Related]
2. Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2.
Lauro ML; D'Ambrosio EA; Bahnson BJ; Grimes CL
ACS Infect Dis; 2017 Apr; 3(4):264-270. PubMed ID: 27748583
[TBL] [Abstract][Full Text] [Related]
3. RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition.
Lipinski S; Grabe N; Jacobs G; Billmann-Born S; Till A; Häsler R; Aden K; Paulsen M; Arlt A; Kraemer L; Hagemann N; Erdmann KS; Schreiber S; Rosenstiel P
Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21426-31. PubMed ID: 23213202
[TBL] [Abstract][Full Text] [Related]
4. The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment.
Grimes CL; Ariyananda Lde Z; Melnyk JE; O'Shea EK
J Am Chem Soc; 2012 Aug; 134(33):13535-7. PubMed ID: 22857257
[TBL] [Abstract][Full Text] [Related]
5. Identification of MDP (muramyl dipeptide)-binding key domains in NOD2 (nucleotide-binding and oligomerization domain-2) receptor of Labeo rohita.
Maharana J; Swain B; Sahoo BR; Dikhit MR; Basu M; Mahapatra AS; Jayasankar P; Samanta M
Fish Physiol Biochem; 2013 Aug; 39(4):1007-23. PubMed ID: 23255217
[TBL] [Abstract][Full Text] [Related]
6. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Salmonella flagellin-induced interleukin-8 in intestinal epithelial cells by muramyl dipeptide.
Huang FC
Cell Immunol; 2012; 278(1-2):1-9. PubMed ID: 23121969
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide.
Mann JK; Shen J; Park S
J Cell Biochem; 2017 May; 118(5):1227-1238. PubMed ID: 27791288
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis.
Zhang S; Zhang S; Hu L; Zhai L; Xue R; Ye J; Chen L; Cheng G; Mruk J; Kunapuli SP; Ding Z
Circulation; 2015 Mar; 131(13):1160-70. PubMed ID: 25825396
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into the MDP binding and CARD-CARD interaction in zebrafish (Danio rerio) NOD2: a molecular dynamics approach.
Maharana J; Patra MC; De BC; Sahoo BR; Behera BK; De S; Pradhan SK
J Mol Recognit; 2014 May; 27(5):260-75. PubMed ID: 24700593
[TBL] [Abstract][Full Text] [Related]
12. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
13. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP).
Brahma B; Patra MC; Mishra P; De BC; Kumar S; Maharana J; Vats A; Ahlawat S; Datta TK; De S
J Mol Graph Model; 2016 Apr; 65():15-26. PubMed ID: 26897084
[TBL] [Abstract][Full Text] [Related]
14. The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease.
Mohanan V; Grimes CL
J Biol Chem; 2014 Jul; 289(27):18987-98. PubMed ID: 24790089
[TBL] [Abstract][Full Text] [Related]
15. Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.
Prakhar P; Holla S; Ghorpade DS; Gilleron M; Puzo G; Udupa V; Balaji KN
J Biol Chem; 2015 Oct; 290(44):26576-86. PubMed ID: 26391398
[TBL] [Abstract][Full Text] [Related]
16. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
[TBL] [Abstract][Full Text] [Related]
17. The NOD2-RICK complex signals from the plasma membrane.
Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
[TBL] [Abstract][Full Text] [Related]
18. The c-Jun N-terminal kinase (JNK)-binding protein (JNKBP1) acts as a negative regulator of NOD2 protein signaling by inhibiting its oligomerization process.
Lecat A; Di Valentin E; Somja J; Jourdan S; Fillet M; Kufer TA; Habraken Y; Sadzot C; Louis E; Delvenne P; Piette J; Legrand-Poels S
J Biol Chem; 2012 Aug; 287(35):29213-26. PubMed ID: 22700971
[TBL] [Abstract][Full Text] [Related]
19. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
20. E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDP.
Bist P; Cheong WS; Ng A; Dikshit N; Kim BH; Pulloor NK; Khameneh HJ; Hedl M; Shenoy AR; Balamuralidhar V; Malik NBA; Hong M; Neutzner A; Chin KC; Kobayashi KS; Bertoletti A; Mortellaro A; Abraham C; MacMicking JD; Xavier RJ; Sukumaran B
Nat Commun; 2017 Jun; 8():15865. PubMed ID: 28656966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
